Non-steroidal anti-inflammatory drugs suppress the ERK signaling pathway via block of Ras/c-Raf interaction and activation of MAP kinase phosphatases.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Cellular Signalling

• Publication date

  2008-06-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.cellsig.2008.02.004PMID 18374541
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• ERK MAP kinase in G1 cell cycle progression and cancer

  2006cited by this paper
• Suppressed MKP-1 Is an Independent Predictor of Outcome in Patients with Hepatocellular Carcinoma

  2005cited by this paper
• Mitogen-Activated Protein Kinase Phosphatase-1 Is Overexpressed in Non-Small Cell Lung Cancer and Is an Independent Predictor of Outcome in Patients

  2004cited by this paper
• COX inhibitors modulate bFGF‐induced cell survival in MCF‐7 breast cancer cells

  2004cited by this paper
• Dynamic Changes in C-Raf Phosphorylation and 14-3-3 Protein Binding in Response to Growth Factor Stimulation

  2004cited by this paper
• Sulindac-derived Ras pathway inhibitors target the Ras-Raf interaction and downstream effectors in the Ras pathway.

  2004cited by this paper
• Structure and regulation of MAPK phosphatases.

  2004cited by this paper
• Cyclooxygenase‐2 inhibitor NS‐398 suppresses cell growth and constitutive production of granulocyte‐colony stimulating factor and granulocyte macrophage‐colony stimulating factor in lung cancer cells

  2003cited by this paper
• Protein phosphatase 2A positively regulates Ras signaling by dephosphorylating KSR1 and Raf-1 on critical 14-3-3 binding sites.

  2003cited by this paper
• The Requirement of Specific Membrane Domains for Raf-1 Phosphorylation and Activation*

  2003cited by this paper
• Degradation of tenascin-C and activity of matrix metalloproteinase-2 are associated with tumor recurrence in early stage non-small cell lung cancer.

  2002cited by this paper
• Nonsteroidal Anti-inflammatory Drugs Inhibit Matrix Metalloproteinase-2 via Suppression of the ERK/Sp1-mediated Transcription*

  2002cited by this paper
• Expression of mitogen‐activated protein kinase phosphatase‐1 (MKP‐1) in primary human ovarian carcinoma

  2002cited by this paper
• Aspirin and NS‐398 inhibit hepatocyte growth factor–induced invasiveness of human hepatoma cells

  2002cited by this paper
• Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues.

  2002cited by this paper
• Regulation of Raf‐1 activation and signalling by dephosphorylation

  2002cited by this paper
• Cyclic AMP-Dependent Kinase Regulates Raf-1 Kinase Mainly by Phosphorylation of Serine 259

  2002cited by this paper
• Positive and negative regulation of Raf kinase activity and function by phosphorylation

  2001cited by this paper
• Akt1 induces extracellular matrix invasion and matrix metalloproteinase-2 activity in mouse mammary epithelial cells.

  2001cited by this paper
• Non‐steroidal anti‐inflammatory drugs inhibit matrix metalloproteinase‐2 expression via repression of transcription in lung cancer cells

  2001cited by this paper
• Suppression of matrix metalloproteinase-2 gene expression and invasion in human glioma cells by MMAC/PTEN

  2001cited by this paper
• Overexpression of matrix metalloproteinase 2 predicts unfavorable outcome in early-stage non-small cell lung cancer.

  2000cited by this paper
• Overexpression of Matrix Metalloproteinase 2 Predicts Unfavorable Outcome in Early-Stage Non-Small Cell Lung Cancer 1

  2000cited by this paper
• FEBS Lett

  2000cited by this paper
• Tissue inhibitors of metalloproteinases: evolution, structure and function.

  2000cited by this paper
• Serine and tyrosine phosphorylations cooperate in Raf‐1, but not B‐Raf activation

  1999cited by this paper
• Matrix Metalloproteinases*

  1999cited by this paper
• Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: Insight into mechanisms and implications for cancer growth and ulcer healing

  1999cited by this paper
• The Transcription Factors Sp1, Sp3, and AP-2 Are Required for Constitutive Matrix Metalloproteinase-2 Gene Expression in Astroglioma Cells*

  1999cited by this paper
• Phosphorylation and regulation of Raf by Akt (protein kinase B).

  1999cited by this paper
• Sulindac sulfide inhibits Ras signaling

  1998cited by this paper
• The Dual Specificity Mitogen-activated Protein Kinase Phosphatase-1 and −2 Are Induced by the p42/p44MAPK Cascade*

  1997cited by this paper
• Expression of interleukin-8 by human melanoma cells up-regulates MMP-2 activity and increases tumor growth and metastasis.

  1997cited by this paper
• Changing views of the role of matrix metalloproteinases in metastasis.

  1997cited by this paper
• Membrane recruitment of Raf-1 is not the only function of Ras in Raf-1 activation

  1997cited by this paper
• Expression of matrix metalloproteinase (gelatinase) in T1 adenocarcinoma of the lung

  1997cited by this paper
• Glioma invasionin vitro: regulation by matrix metalloprotease-2 and protein kinase C

  1996cited by this paper
• Matrix metalloproteinases and tumor invasion: from correlation and causality to the clinic.

  1996cited by this paper
• Glioma invasion in vitro: regulation by matrix metalloprotease-2 and protein kinase C.

  1996cited by this paper
• Association between expression of activated 72-kilodalton gelatinase and tumor spread in non-small-cell lung carcinoma.

  1993cited by this paper
• MKP-1 (3CH134), an immediate early gene product, is a dual specificity phosphatase that dephosphorylates MAP kinase in vivo.

  1993cited by this paper
• Structural biochemistry and activation of matrix metalloproteases.

  1993cited by this paper
• Cytokine regulation of metalloproteinase gene expression

  1993cited by this paper

• Concomitant medication effects on patients with lung cancer taking immune checkpoint inhibitors a review

  2025cites this paper
• Sulindac Sulfide Suppresses Oncogenic Transformation Through let-7b-Mediated Repression of K-Ras Signaling

  2025cites this paper
• Sulindac sulfide suppresses oncogenic transformation through let-7b-mediated repression of K-Ras signaling

  2025cites this paper
• The Expendables: Overlooked Medications with Anti-Cancer Properties

  2025cites this paper
• A Contemporary Review on the Critical Role of Nonsteroidal Anti-inflammatory Agents in Colorectal Cancer Therapy.

  2024cites this paper
• Drug repurposing in the treatment of chronic inflammatory diseases

  2024cites this paper
• Acetylsalicylic Acid with Ascorbate: A Promising Combination Therapy for Solid Tumors

  2024cites this paper
• Aspirin as a potential drug repurposing candidate targeting estrogen receptor alpha in breast cancer: a molecular dynamics and in-vitro study

  2024cites this paper
• LaSOM 335, active against bladder cancer cells, interferes with Let‐60 (hRas) and reduces CD73 expression/activity

  2023cites this paper
• Colorectal Cancer Screening History, Methods and Future Perspectives

  2023cites this paper
• Aspirin Repurposing in Folate-Decorated Nanoparticles: Another Way to Target Breast Cancer

  2022cites this paper
• Low-dose aspirin prevents LPS-induced preeclampsia-like phenotype via AQP-1 and the MAPK/ERK 1/2 pathway.

  2022cites this paper
• Colorectal cancer chemoprevention: is aspirin still in the game?

  2022cites this paper
• Aspirin and cancer: biological mechanisms and clinical outcomes

  2022cites this paper
• Platelet-Cancer Interplay: Molecular Mechanisms and New Therapeutic Avenues

  2021cites this paper
• Aspirin and antiplatelet treatments in cancer

  2021cites this paper
• Analgesia for Sheep in Commercial Production: Where to Next?

  2021cites this paper
• LncRNAs and Immunity: Coding the Immune System with Noncoding Oligonucleotides

  2021cites this paper
• Prostate Apoptosis Response-4 in Inflammation

  2021cites this paper
• An Evaluation of the Inhibition Effects of Cell Migration of Aspirin Soaking 360°Square-Edge Intraocular Lens in an in Vitro Lens Capsule Model

  2021cites this paper
• Post-Translational Regulation of the Activity of ERK/MAPK and PI3K/AKT Signaling Pathways in Neuroblastoma Cancer

  2021cites this paper
• Exploratory Genome-Wide Interaction Analysis of Nonsteroidal Anti-inflammatory Drugs and Predicted Gene Expression on Colorectal Cancer Risk

  2020cites this paper
• Drug Repurposing Approaches: Existing Leads For Novel Threats And Drug Targets.

  2020cites this paper
• Small molecule inhibitors of RAS proteins with oncogenic mutations

  2020cites this paper
• Resveratrol and Resveratrol-Aspirin Hybrid Compounds as Potent Intestinal Anti-Inflammatory and Anti-Tumor Drugs

  2020cites this paper
• Effects of chronic low‐dose aspirin treatment on tumor prevention in three mouse models of intestinal tumorigenesis

  2020cites this paper
• Drugging the Small GTPase Pathways in Cancer Treatment: Promises and Challenges

  2019cites this paper
• Beyond a chemopreventive reagent, aspirin is a master regulator of the hallmarks of cancer

  2019cites this paper
• Dihydroartemisinin derivative DC32 inhibits inflammatory response in osteoarthritic synovium through regulating Nrf2/NF-κB pathway.

  2019cites this paper
• Role of the Extracellular Signal-Regulated Kinase 1/2 Signaling Pathway in Ischemia-Reperfusion Injury

  2019cites this paper
• From basic researches to new achievements in therapeutic strategies of KRAS-driven cancers

  2019cites this paper
• Upregulated NPM1 is an independent biomarker to predict progression and prognosis of oral squamous cell carcinomas in Taiwan

  2019cites this paper
• Acibenzolar-S-Methyl Inhibits MEK1/2 Signaling in SH-SY5Y Neuroblastoma Cells

  2019influential citation
• The selective cyclooxygenase-2 inhibitor mavacoxib (Trocoxil) exerts anti-tumour effects in vitro independent of cyclooxygenase-2 expression levels.

  2019cites this paper
• Edinburgh Research Explorer The selective cyclooxygenase-2 inhibitor mavacoxib (Trocoxcil™) exerts anti-tumour effects in-vitro independent of cyclooxygenase-2 expression levels

  2019cites this paper
• Aspirin Affects Tumor Angiogenesis and Sensitizes Human Glioblastoma Endothelial Cells to Temozolomide, Bevacizumab, and Sunitinib, Impairing Vascular Endothelial Growth Factor-Related Signaling.

  2018cites this paper
• Influence of Smoking, Body Mass Index, and Other Factors on the Preventive Effect of Nonsteroidal Anti-Inflammatory Drugs on Colorectal Cancer Risk.

  2018cites this paper
• Drug repurposing in cancer.

  2017cites this paper
• Arresting kinase suppressor of Ras in an inactive state

  2017cites this paper
• The RAS-Effector Interaction as a Drug Target.

  2017cites this paper
• Anti-androgen 2-hydroxyflutamide modulates cadherin, catenin and androgen receptor phosphorylation in androgen-sensitive LNCaP and androgen-independent PC3 prostate cancer cell lines acting via PI3K/Akt and MAPK/ERK1/2 pathways.

  2017cites this paper
• Prevention and treatment of cancer targeting chronic inflammation: research progress, potential agents, clinical studies and mechanisms

  2017cites this paper
• Exploratory plasma proteomic analysis in a randomized crossover trial of aspirin among healthy men and women

  2017cites this paper
• Reduction of NANOG Mediates the Inhibitory Effect of Aspirin on Tumor Growth and Stemness in Colorectal Cancer

  2017cites this paper
• Search for Inhibitors of Ras-Driven Cancers

  2017cites this paper
• Mechanisms of nonsteroidal anti-inflammatory drugs in cancer prevention.

  2016cites this paper
• The aspirin-induced long non-coding RNA OLA1P2 blocks phosphorylated STAT3 homodimer formation

  2016cites this paper
• Direct small-molecule inhibitors of KRAS: from structural insights to mechanism-based design

  2016cites this paper
• Synthesis and Biological Evaluation of Novel Indomethacin Derivatives as Potential Anti‐Colon Cancer Agents

  2016cites this paper
• Aspirin in pancreatic cancer: chemopreventive effects and therapeutic potentials.

  2016cites this paper
• Past, Present, and Future of Targeting Ras for Cancer Therapies.

  2016cites this paper
• Novel Cellular Targets of Aspirin in Chemoprevention studies on P53, G6PD and c-MYC

  2016cites this paper
• Molecular and Experimental Basis for COX Inhibition in Cancer

  2016cites this paper
• Aspirin and the Prevention of Colorectal Cancer

  2016cites this paper
• Protective effects of intestinal trefoil factor (ITF) on gastric mucosal epithelium through activation of extracellular signal-regulated kinase 1/2 (ERK1/2)

  2015cites this paper
• Synthesis, characterization, and biological activity of transition metals complexes with mefenamic acid (NSAIDs)

  2015cites this paper
• New Insights into the Mechanism of Action of Aspirin in the Prevention of Colorectal Neoplasia.

  2015cites this paper
• Aspirin Use on Incidence and Mortality of Gastrointestinal Cancers: Current State of Epidemiological Evidence.

  2015cites this paper
• Molecular targets of aspirin and cancer prevention

  2014cites this paper
• Cyclooxygenase inhibitors inhibit antibody response through interference with MAPK/ERK pathways and BLIMP-1 inhibition.

  2014cites this paper
• Ibuprofen treatment blunts early translational signaling responses in human skeletal muscle following resistance exercise.

  2014cites this paper
• The preventive effects of low-dose enteric-coated aspirin tablets on the development of colorectal tumours in Asian patients: a randomised trial

  2014cites this paper
• responses in human skeletal muscle following resistance

  2014cites this paper
• ROLES OF INOSITOL DIPHOSPHATES IN DNA REPAIR AND EFFECTS OF ASPIRIN ANALOGUES ON OESOPHAGEAL CANCER

  2014cites this paper
• Mode of action of aspirin as a chemopreventive agent.

  2013influential citation
• Prevention and intervention trials for colorectal cancer.

  2013cites this paper
• Coxibs: pharmacology, toxicity and efficacy in cancer clinical trials.

  2013cites this paper
• Mechanistic and Pharmacological Issues of Aspirin as an Anticancer Agent

  2012cites this paper
• Inflammatory signaling in skeletal muscle cell growth

  2012cites this paper
• Berberine Inhibits Pulmonary Metastasis through Down‐regulation of MMP in Metastatic B16F‐10 Melanoma Cells

  2012cites this paper
• Studies on anti-metastatic and anti-invasive effects of harmine using highly metastatic murine B16F-10 melanoma cells.

  2011cites this paper
• Weak up-regulation of serum response factor in gastric ulcers in patients with co-morbidities is associated with increased risk of recurrent bleeding

  2011cites this paper
• Prion peptide-mediated cellular prion protein overexpression and neuronal cell death can be blocked by aspirin treatment.

  2011cites this paper
• Areca nut extract induced oxidative stress and upregulated hypoxia inducing factor leading to autophagy in oral cancer cells

  2010cites this paper
• R-flurbiprofen reverses multidrug resistance, proliferation and metastasis in gastric cancer cells by p75(NTR) induction.

  2010cites this paper
• NSAIDs and Cell Proliferation in Colorectal Cancer

  2010cites this paper
• Heparin treatment of vascular smooth muscle cells results in the synthesis of the dual‐specificity phosphatase MKP‐1

  2010cites this paper
• Rosiglitazone reduces cell invasiveness by inducing MKP-1 in human U87MG glioma cells.

  2009cites this paper
• Triptolide Inhibits the Proliferation of Immortalized HT22 Hippocampal Cells Via Persistent Activation of Extracellular Signal-Regulated Kinase-1/2 by Down-Regulating Mitogen-Activated Protein Kinase Phosphatase-1 Expression.

  2009cites this paper
• Targeted delivery of anti-inflammatory agents to tumors.

  2009cites this paper
• Anti-Inflammatory Agents for Cancer Therapy.

  2009cites this paper
• Inhibition of Cyclooxygenase-2 Down-regulates Aromatase Activity and Decreases Proliferation of Leydig Tumor Cells*

  2009cites this paper
• Role of T cells in nonimmediate allergic drug reactions

  2009cites this paper
• Anti‐metastatic Action of Non‐steroidal Anti‐inflammatory Drugs

  2008cites this paper